Skip to content

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

A Phase 2, Multicenter, Observational Study to Assess the Durability and Safety of Collagenase Clostridium Histolyticum Injected With GRID Technique in Buttocks or Thigh Cellulite With Laxity in Adult Females

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05249257
Enrollment
20
Registered
2022-02-21
Start date
2022-01-25
Completion date
2022-09-12
Last updated
2023-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cellulite, Edematous Fibrosclerotic Panniculopathy, Laxity; Skin

Brief summary

All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.

Interventions

None listed

Sponsors

Endo Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Have participated in and completed study EN3835-224 (parent study). 2. Be willing and able to cooperate with the requirements of the study.

Exclusion criteria

1. Has received any collagenase treatments (eg, Santyl® Ointment) at any time since 2. Has had any surgery, invasive procedure (eg, liposuction), injectable treatment (eg, KYBELLA®) or any similar treatment in the area treated during the EN3835-224 study since the completion of that study. 3. Has any other conditions that, in the investigator's opinion, might indicate the participant to be unsuitable for the study

Design outcomes

Primary

MeasureTime frameDescription
Proportion of 1-level responders (+1 or better score) on the I-GAIS for either buttock or either thighDay 360Investigator Global Aesthetic Improvement Scale (I-GAIS) is a 7-level scale ranging from +3 (very much improved) to -3 (very much worse) to determine the degree of improvement of the treated areas

Secondary

MeasureTime frameDescription
Change from Day 1 (pre-treatment) of the parent study and each study visit in Subsection D of the Hexsel CSSDay 360 and Day 540Hexsel CSS is a photonumeric scale that looks at 5 key morphologic features of cellulite using a 4-point scale ranging from 0 (low) to 3 (high).
I-GAIS ratingsDay 360 and Day 540Investigator Global Aesthetic Improvement Scale (I-GAIS) is a 7-level scale ranging from +3 (very much improved) to a -3 (very much worse) to determine the degree of improvement of the treated areas.
Proportion of 1-level responders (+1 or better score) on the S-GAIS for either buttock or either thighDay 360 and Day 540Subject Global Aesthetic Improvement Scale (S-GAIS) is a 7-level scale ranging from +3 (very much improved) to a -3 (very much worse).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026